INCY
#534
Incyte Corporation - Common Stock
112.7 9 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.04%
Variación mensual
-7.91%
Variación en los últimos 6 meses
+17.33%
Cambio anual
+33.72%
Cierres anteriores
112.7 5
Open
112.3 5
Mínimo
111.8 1
Máximo
113.8 7
Financials
- Market Capitalization 22.86 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
15.41
Relación precio/flujo de caja
3.86
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 524 |  UTHR United Therapeutics Corporation - Common Stock | 549.16 USD | +3.07% | +1.60% | +8.38% | +25.51% | 23.55 B USD | ||
| 528 |  BNTX BioNTech SE - American Depositary Shares | 96.96 USD | +5.32% | +0.23% | -4.95% | -4.94% | 23.27 B USD | ||
| 543 |  INSM Insmed Incorporated - Common Stock | 100.60 USD | +0.12% | -4.64% | -22.32% | -37.92% | 21.97 B USD | ||
| 685 |  EXEL Exelixis, Inc. - Common Stock | 59.86 USD | +1.42% | +2.57% | +6.06% | +53.33% | 14.83 B USD |